skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 24  for All Library Resources

Results 1 2 next page
Refined by: subject: Humans remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Syncytia formation by SARS‐CoV‐2‐infected cells
Material Type:
Article
Add to My Research

Syncytia formation by SARS‐CoV‐2‐infected cells

The EMBO journal, 2020-12, Vol.39 (23), p.e106267-n/a [Peer Reviewed Journal]

2020 The Authors ;2020 The Authors. ;2020 EMBO ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2020106267 ;PMID: 33051876

Full text available

2
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Material Type:
Article
Add to My Research

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Nature communications, 2023-02, Vol.14 (1), p.824-824, Article 824 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-36561-6 ;PMID: 36788246

Full text available

3
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Material Type:
Article
Add to My Research

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion

Nature communications, 2024-03, Vol.15 (1), p.2254-2254 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2024 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-46490-7 ;PMID: 38480689

Full text available

4
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
Material Type:
Article
Add to My Research

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine

Frontiers in immunology, 2022-02, Vol.13, p.790212 [Peer Reviewed Journal]

Copyright © 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer. ;Attribution ;Copyright © 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.790212 ;PMID: 35281046

Full text available

5
Divergent adaptive immune responses define two types of long COVID
Material Type:
Article
Add to My Research

Divergent adaptive immune responses define two types of long COVID

Frontiers in immunology, 2023-07, Vol.14, p.1221961-1221961 [Peer Reviewed Journal]

Copyright © 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti. ;Attribution ;Copyright © 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2023.1221961 ;PMID: 37559726

Full text available

6
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
Material Type:
Article
Add to My Research

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination

Viruses, 2022-07, Vol.14 (7), p.1491 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2022 by the authors. 2022 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v14071491 ;PMID: 35891471

Full text available

7
Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation
Material Type:
Article
Add to My Research

Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation

PLoS pathogens, 2017-07, Vol.13 (7), p.e1006460 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Zhyvoloup A, Melamed A, Anderson I, Planas D, Lee C-H, Kriston-Vizi J, et al. (2017) Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation. PLoS Pathog 13(7): e1006460. https://doi.org/10.1371/journal.ppat.1006460 ;Distributed under a Creative Commons Attribution 4.0 International License ;2017 Zhyvoloup et al 2017 Zhyvoloup et al ;2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Zhyvoloup A, Melamed A, Anderson I, Planas D, Lee C-H, Kriston-Vizi J, et al. (2017) Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation. PLoS Pathog 13(7): e1006460. https://doi.org/10.1371/journal.ppat.1006460 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1006460 ;PMID: 28727807

Full text available

8
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study
Material Type:
Article
Add to My Research

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

EBioMedicine, 2021-11, Vol.73, p.103637-103637, Article 103637 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2021 The Authors 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103637 ;PMID: 34678613

Full text available

9
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Material Type:
Article
Add to My Research

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

EBioMedicine, 2022-03, Vol.77, p.103934-103934, Article 103934 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2022.103934 ;PMID: 35290827

Full text available

10
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Material Type:
Article
Add to My Research

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Nature (London), 2022-02, Vol.602 (7898), p.671-675 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04389-z ;PMID: 35016199

Full text available

11
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Material Type:
Article
Add to My Research

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Science Translational Medicine, 2020-09, Vol.12 (559) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1946-6234 ;EISSN: 1946-6242 ;DOI: 10.1126/scitranslmed.abc3103 ;PMID: 32817357

Digital Resources/Online E-Resources

12
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
Material Type:
Article
Add to My Research

Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases

Annals of the rheumatic diseases, 2022-05, Vol.81 (5), p.720-728 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2021-221508 ;PMID: 35022159

Full text available

13
Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab
Material Type:
Article
Add to My Research

Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab

American journal of transplantation, 2022-08, Vol.22 (8), p.2099-2103 [Peer Reviewed Journal]

2022 The American Society of Transplantation and the American Society of Transplant Surgeons. ;2022 The American Society of Transplantation and the American Society of Transplant Surgeons ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.17000 ;PMID: 35150193

Full text available

14
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Material Type:
Article
Add to My Research

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Proceedings of the National Academy of Sciences - PNAS, 2022-05, Vol.119 (20), p.e2120976119-e2120976119 [Peer Reviewed Journal]

Copyright National Academy of Sciences May 17, 2022 ;Attribution ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120976119 ;PMID: 35549549

Full text available

15
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
Material Type:
Article
Add to My Research

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Blood, 2022-02, Vol.139 (6), p.942-946 [Peer Reviewed Journal]

2022 American Society of Hematology ;Copyright ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013714 ;PMID: 34905598

Full text available

16
Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth
Material Type:
Article
Add to My Research

Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth

Proceedings of the National Academy of Sciences - PNAS, 2021-11, Vol.118 (48) [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Nov 30, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2105927118 ;PMID: 34819367

Full text available

17
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Material Type:
Article
Add to My Research

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

Journal of virology, 2024-01 [Peer Reviewed Journal]

Copyright ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.01351-23 ;PMID: 38088562

Digital Resources/Online E-Resources

18
Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol
Material Type:
Article
Add to My Research

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol

BMJ open, 2019-04, Vol.9 (4), p.e028444-e028444 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-028444 ;PMID: 31005944

Full text available

19
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
Material Type:
Article
Add to My Research

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection

The Journal of infectious diseases, 2021-11, Vol.224 (9), p.1489-1499 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab375 ;PMID: 34282461

Full text available

20
Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysis
Material Type:
Article
Add to My Research

Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysis

Clinical pharmacology and therapeutics, 2024-01 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.3069 ;PMID: 37795693

Digital Resources/Online E-Resources

Results 1 - 20 of 24  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2015  (1)
  2. 2015 To 2016  (1)
  3. 2017 To 2018  (1)
  4. 2019 To 2020  (3)
  5. After 2020  (19)
  6. More options open sub menu

Searching Remote Databases, Please Wait